Yahoo Web Search

Search results

1. • 2,145 Shares in Novartis AG (NYSE:NVS) Bought by Wealthcare Advisory Partners LLC

     ETF DAILY NEWS· 23 hours ago

     Wealthcare Advisory Partners LLC bought a new stake in Novartis AG (NYSE:NVS – Free Report) during the fourth quarter, according to the company ...

2. • Novartis AG ADR (NVS) Stock: Analyzing the Market Value – News Heater

     NewsHeater· 3 days ago

     The average trading volume for NVS on May 09, 2024 was 1.61M shares. The stock of Novartis AG ADR (NYSE: NVS) has increased by 0.53 when compared to last ...

3. • 

     2 Magnificent Dividend Stocks to Hold for the Next Decade

     Motley Fool via Yahoo Finance· 7 days ago

     Its dividend yield of 0.77% and cash payout ratio of 20% indicate that, if anything, the company has...

4. • 

     Google DeepMind Develops Latest AI Model To Aid Scientists In Fighting Disease - Alphabet...

     Benzinga· 3 days ago

     Researchers at Alphabet Inc’s GOOG GOOGL Google DeepMind have developed AlphaFold 3, an new...

5. • The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - April 2024 | JD...

     JD Supra· 5 days ago

     This week, the FTC continued its intense regulatory focus on pharmaceutical patents listed in the FDA’s Orange Book. As reported in earlier editions of The Interplay, the FTC issued a policy ...

6. • TFF Pharmaceuticals (NASDAQ:TFFP) vs. Alnylam Pharmaceuticals (NASDAQ:ALNY) Financial Contrast

     ETF DAILY NEWS· 2 days ago

     Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) are both medical companies, but which is the better business? We will contrast ...

7. • Study: For treating retinopathy of prematurity, UB-led research proves that ranibizumab is safe

     UB Reporter· 1 day ago

     A University at Buffalo researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition. ROP occurs in low ...

8. • 

     Tweedy Browne Funds' 1st-Quarter Commentary: A Recap

     Guru Focus· 2 days ago

     Coming on the heels of one of their best performances in two decades, global equity markets continued their robust advance into the new year and finished...